Aims To evaluate the efficacy and safety of ezetimibe 10mg administered with pravastatin in
patients with primary hypercholesterolemia. Methods and results After dietary stabilization, 2 …

Although large-scale statin trials have demonstrated significant reductions in cardiovascular
risk, there are many patients who have a cardiovascular event despite receiving statin …

Statin–ezetimibe combinations are a potentially advantageous therapeutic option for high-
risk patients who need additional lowering of low-density lipoprotein cholesterol (LDL-C) …

The combination of Simvastatin and Ezetimibe allows dual inhibition of both cholesterol
production and absorption. This treatment approach allows achieving same low serum …

BACKGROUND:: Rosuvastatin is a new statin indicated to reduce elevated levels of total
cholesterol, low-density lipoprotein cholesterol (LDL-C), and triglycerides and to increase …

Purpose Rosuvastatin is a synthetic 3-hydroxy-3-methylglutaryl coenzyme A reductase
inhibitor that effectively reduces low-density lipoprotein cholesterol levels. However, statin …

Background and objective Rosuvastatin and ezetimibe are commonly applied in lipid-
lowering pharmacotherapy. However, the pharmacokinetic (PK) interaction was not clear by …

The cardiovascular benefits of therapy with the 3-hydroxy-3-methylglutaryl coenzyme A
reductase inhibitors (statins) are well documented. Undertreatment of dyslipidemia remains …

Co‐administration of ezetimibe with atorvastatin is a generally well‐tolerated treatment
option that reduces LDL‐C levels and improves other lipids with greater efficacy than …

Full article: The role of ezetimibe in LDL cholesterol goal attainment in very high risk patients:
the rosuvastatin monotherapy looks to be insufficient Skip to Main Content Taylor and Francis …